Genetic Polymorphisms and Pharmacotherapy for Prostate Cancer

The therapeutic landscape of pharmacotherapy for prostate cancer has dramatically evolved, and multiple therapeutic options have become available for prostate cancer patients. Therefore, useful biomarkers to identify suitable candidates for treatment are required to maximize the efficacy of pharmaco...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiota, Masaki, Akamatsu, Shusuke, Narita, Shintaro, Terada, Naoki, Fujimoto, Naohiro, Eto, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Medical Association 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119070/
https://www.ncbi.nlm.nih.gov/pubmed/33997443
http://dx.doi.org/10.31662/jmaj.2021-0004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119070/
https://www.ncbi.nlm.nih.gov/pubmed/33997443
http://dx.doi.org/10.31662/jmaj.2021-0004

Ejemplares similares